Fund shareholders of WaVe Life Sciences Ltd
ISIN SG9999014716 · Singapore · LEI 54930070006GPKFYZ813
- Fund shareholders
- 208
- Of which ETFs
- 46 162 other funds
- Value held
- 362.1M $ 17.4K € · 4.5M SEK
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| SMALL-CAP PROFUND ProFunds | 255 | 1.8K $ | 0.02 % | as of Apr 30, 2026 ↗ |
| Kennedy Capital Small Cap Growth Fund INVESTMENT MANAGERS SERIES TRUST II | 224 | 1.6K $ | 0.33 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 196 | 1.4K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 188 | 1.4K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 119 | 1.7K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 36 | 261 $ | 0.01 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 35 | 487.6 $ | 0.04 % | as of Feb 28, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 17.4K € | 0.47 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 4.21 % | as of Feb 28, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 1.50 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 0.99 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 0.95 % | as of Mar 31, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 0.91 % | as of Feb 28, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 0.67 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 0.66 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Small Cap Equity ETF Goldman Sachs ETF Trust | 0.57 % | as of Feb 28, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 0.54 % | as of Mar 31, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 0.47 % | as of Dec 31, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 206 | +1 | 40,191,535 | -13.4 % |
| 2026Q1 | 205 | +20 | 46,386,347 | +35.7 % |
| 2025Q4 | 185 | +12 | 34,173,702 | +17.1 % |
| 2025Q3 | 173 | -13 | 29,187,880 | +1.9 % |
| 2025Q2 | 186 | +6 | 28,643,131 | +1.8 % |
| 2025Q1 | 180 | +32 | 28,127,019 | +27.4 % |
| 2024Q4 | 148 | +15 | 22,075,695 | +46.1 % |
| 2024Q3 | 133 | +11 | 15,111,988 | +17.4 % |
| 2024Q2 | 122 | +16 | 12,876,172 | +19.9 % |
| 2024Q1 | 106 | +12 | 10,737,604 | +4.6 % |
| 2023Q4 | 94 | 10,268,700 |
Cite this page
Titelia. "Fund shareholders of WaVe Life Sciences Ltd". https://titelia.com/en/stocks/wave-life-sciences-ltd-SG9999014716